Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension - Wikidata - wikimedia - TriplyDB

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

http://www.wikidata.org/entity/Q33712644

about

Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series)Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.Coenzyme Q supplementation in pulmonary arterial hypertension.NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension An official American Thoracic Society Statement: pulmonary hypertension phenotypes Natural antioxidant dihydroxybenzyl alcohol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human endothelial cells.PGC-1α induction in pulmonary arterial hypertension NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.Reactive oxygen species in pulmonary vascular remodeling.Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension.Role of reactive oxygen species in neonatal pulmonary vascular disease.Melatonin and Human Cardiovascular Disease.Electromagnetic Fields and Stem Cell Fate: When Physics Meets Biology.Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension.Melatonin as a preventive and curative therapy against pulmonary hypertension.Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.Altered Redox Balance in the Development of Chronic Hypoxia-induced Pulmonary Hypertension.Redox Regulation of the Superoxide Dismutases SOD3 and SOD2 in the Pulmonary Circulation.Molecular Basis of Nitrative Stress in the Pathogenesis of Pulmonary Hypertension.Adventitial Fibroblast Nox4 Expression and ROS Signaling in Pulmonary Arterial Hypertension.Endothelial Cell Metabolism.Recurrent inhibition of mitochondrial complex III induces chronic pulmonary vasoconstriction and glycolytic switch in the rat lung.

P2860

Q26772286-3BD955C9-5031-47F8-8489-2C86EB2A5CBA Q26859449-3EAEDDD6-BE5C-4075-9EA4-50B4782ED364 Q33703652-8B2104A7-4980-42E0-B7CE-55EC322B43D8 Q34085977-9C88C155-B385-414C-971D-B33DE166E713 Q34495678-75FD6A21-10B7-4086-B28C-62F2267ED0F1 Q34627552-F7CC2A87-ECA4-4D0E-972D-B9DECB53FC97 Q34919733-8233BA5A-2E11-4CC6-A8FF-EEC4316B8E2A Q35739410-61B29B03-2E5E-4732-8668-77501A3C8FAA Q36221045-CA877647-959D-4E4C-AC2F-463B7E0BE93B Q36837739-2FB7077E-9038-4FB7-B9C3-9F700A5A9F5D Q37139542-E8348D9C-A2DE-46DC-A6BF-7DEE0837EF4B Q37532988-C7EF87A4-1915-4D46-AF11-9A169CBF9570 Q38112040-4B894A1A-2EDA-4D64-BA39-1498780D2EAD Q38172267-B46A4795-4E52-4DBA-B56E-B9EB31288136 Q38906296-487320C7-E3E1-4C00-A067-E168AE2A4318 Q38925328-CC080ED6-2705-4006-8C3A-11D5B885C747 Q39419466-92A49A00-A541-4C39-854D-F31B6307A807 Q40708102-36E581D4-4326-4406-A1BF-4091E851C00B Q40987019-5B0FD38E-B7BC-405D-A85B-5CA0F590316D Q43712141-C905A3D2-BD28-4074-A9B9-C474D80E3011 Q46280877-8BF53C02-1B7E-45A6-9B7E-94774099B2C7 Q46280886-EBC69CB3-5F54-4526-A7A4-8786727B06A5 Q46280900-19586BAF-1AA2-43CD-8EC8-9DA8ED988B59 Q46280910-E01FD1EB-AFC5-4F59-B62E-4C112AF013A6 Q49787990-8595CB53-B99F-4F6D-B017-24CFC7212519 Q52312349-061D0C02-C4C8-4D68-BC70-33139427DC5A

P2860

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

http://www.wikidata.org/entity/Q33712644

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

@ast

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

@en

type

label

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

@ast

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

@en

prefLabel

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

@ast

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

@en

P1433

Q33712644-6A45869D-D790-4D7C-AB80-04577D90E714

P1476

Q33712644-2C874C40-E934-4C9D-A26D-D10DBF3ADBC1

P2093

Q33712644-000D1F10-60A8-4252-B63D-2D8373D43C4C

Q33712644-52C9B956-A470-41A0-B35F-3AAAA5E81E85

Q33712644-6EB39794-1F37-4D59-93D2-D6EFA947EC6B

Q33712644-70B01B30-0E49-42EA-9061-33777C8A9BD3

Q33712644-A3FF5397-0004-461A-A254-9F66D9DA2980

Q33712644-CA5F06A8-70F7-4F66-BF06-3149C18D6D40

Q33712644-D2FF464E-7A15-4BC3-A081-1C43A9C64DA4

P2860

Q33712644-078783BE-4BFD-43EC-AA11-768CDF4C4FAF

Q33712644-0C27EB42-0E3D-45C1-8EB5-32B932527885

Q33712644-1207731F-E685-4E8C-AD3D-1397E4F055E9

Q33712644-12801BAF-CC44-4E33-BC8D-8EA0C44E4A41

Q33712644-14D51CD3-F297-4908-B1D4-46AB3CE1D6F5

Q33712644-1FB5914B-7D91-4772-88FA-2CEC210C55C7

Q33712644-245D1F8C-7AD5-4559-8192-364A0C191FE1

Q33712644-26CFA68F-6907-4B48-BC9A-12A754427B51

Q33712644-2BF8EE7A-69F1-4D5F-8807-F203D1F3BAE6

Q33712644-2D10B053-E858-4E2C-8D5A-2372CAE50697

P304

Q33712644-0A1700A3-C5A9-4371-95A6-2CD00288B3E5

P31

Q33712644-A5503546-E1A5-4F66-95AD-D4BF5880073B

P356

Q33712644-B72D48D2-8750-4FE2-9F3B-097FE6DEC551

P407

Q33712644-BF480A88-5A07-45BD-BDDE-3EFECD8EBA34

P433

Q33712644-92063B19-9E09-404B-B45A-3A048B1BF512

P478

Q33712644-BBC20C55-FA34-4EB2-9AF6-D61D6C81889D

P577

Q33712644-CF588DDF-B394-42CE-AD4C-A8621DE53109

P698

Q33712644-B3FEDAD8-C53B-42A6-AF5C-4FA2E6A9231A

P932

Q33712644-F3A0031A-C9DB-4BEC-9686-54E77B90160E

P356

J.1752-8062.2008.00035.X

P1433

Clinical and Translational Science

P1476

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

@en

P2093

Alejandro C Arroliga

http://www.w3.org/2001/XMLSchema#string

Fares A Masri

http://www.w3.org/2001/XMLSchema#string

Francisco Takao Kaneko

http://www.w3.org/2001/XMLSchema#string

Iva Dostanic-Larson

http://www.w3.org/2001/XMLSchema#string

Raed A Dweik

http://www.w3.org/2001/XMLSchema#string

Serpil C Erzurum

http://www.w3.org/2001/XMLSchema#string

Suzy A A Comhair

http://www.w3.org/2001/XMLSchema#string

P2860

Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease

Structural Characterization of Zinc-deficient Human Superoxide Dismutase and Implications for ALS

Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training

Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure

Human copper-containing superoxide dismutase of high molecular weight

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

Exercise training in coronary artery disease and coronary vasomotion.

Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

Primary pulmonary hypertension. A national prospective study.

Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation.

P304

99-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1752-8062.2008.00035.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20443830

http://www.w3.org/2001/XMLSchema#string

P932

5439561

http://www.w3.org/2001/XMLSchema#string